Overcoming Resistance to HER2 Inhibitors Through State-Specific Kinase Binding

Nature Chemical Biology - United Kingdom
doi 10.1038/nchembio.2171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Overcoming Resistance to Inhibitors of the Akt Protein Kinase by Modulation of the Pim Kinase Pathway

2014English

Treating Cancer With Phosphatidylinositol-3-Kinase Inhibitors: Increasing Efficacy and Overcoming Resistance

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2019English

Anaplastic Lymphoma Kinase Confers Resistance to BRAF Kinase Inhibitors in Melanoma

iScience
Multidisciplinary
2019English

Overcoming Resistance to First/Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and ALK Inhibitors in Oncogene-Addicted Advanced Non-Small Cell Lung Cancer

Therapeutic Advances in Medical Oncology
Oncology
2016English

Src, a Potential Target for Overcoming Trastuzumab Resistance in HER2-positive Breast Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2014English

Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Correction: Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors With Three Different Drug Combinations

PLoS ONE
Multidisciplinary
2016English

Overcoming Resistance Against HER2-Targeting Agents in Fifth-Line Therapy: Is There Still a Place for Bevacizumab in HER2+ Breast Cancer?

Clinical Breast Cancer
Cancer ResearchOncology
2014English

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance

Cancers
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy